FDA may be looking to expand its efforts and programs that train foreign governments to fight substandard and counterfeit drug makers and improve regulatory capacity.
Existing programs could be expanded by collaborating with the State Department and almost certainly would fit into the agency’s plans to deal with the globalization of the industry. FDA has...